Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 614

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 614
---
 |   |     |         |     * |   |     |                             |      80,000 |     |     |       |     * |   |     |              |         — |     |       |   — |   |     |         |     * |   |

| * | Less than 1% |

| ** | Calculated based on the total number of voting shares outstanding. Pre-Business Combination, this includes all                                                                                                                                     
 outstanding Denali Class A Ordinary Shares and Denali Class B Ordinary Shares, as both classes generally have one vote per share and vote as a single class on all matters submitted to stockholders for approval, subject to certain              
 exceptions, including the Domestication Proposal. Post-Business Combination, this includes all shares of New Semnur Common Stock and New Semnur Series A Preferred Stock, as both classes will have one vote per share and vote as a single class. |

| (1) | The business address of each of the following individuals is 437 Madison Avenue, 27th Floor, New 
 York, New York 10022.                                                                            |

389

| (2) | The business address of each of the following individuals is 960 San Antonio Road, Palo Alto, CA 94303. |

| (3) | Consists of 3,895,833 shares subject to options exercisable within 60 days of June 30, 2025 (assuming 
 approval of the Option Exchange Proposal and closing of the Business Combination).                    |

| (4) | Consists of 3,895,833 shares subject to options exercisable within 60 days of June 30, 2025 (assuming 
 approval of the Option Exchange Proposal and closing of the Business Combination).                    |

| (5) | Consists of 458,333 shares subject to options exercisable within 60 days of June 30, 2025 (assuming 
 approval of the Option Exchange Proposal and closing of the Business Combination).                  |

| (6) | Jiandong (Peter) Xu is the manager and controlling member of the Sponsor. As such, each of the Sponsor and                                                                                                                                    
 Mr. Xu may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor. Mr. Xu disclaims any beneficial ownership of the ordinary shares held directly by the Sponsor, and disclaims any beneficial ownership 
 of such shares other than to the extent of any pecuniary interest each may have therein, directly or indirectly. The business address of the Sponsor is